ERBB3 and colorectal carcinoma: In the present paper, we evaluated the immunohistochemical expression and the prognostic value of HER-3 in a cohort of early-stage CRC and in a second set of advanced metastatic CRC patients of whom both the primary tumors and corresponding synchronous and metachronous liver metastasis were available.